SRRK
SRRK
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$12.00M
Insider Sales
0
$0
Total Volume
$12.00M
1 transactions
Net Activity
+$12.00M
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Akkaraju Srinivas
Dir
$12.00M total
Quick Actions
SRRK has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at SRRK (SRRK) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $12.00M.
The net insider activity for SRRK shows a net buying bias of $12.00M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by Akkaraju Srinivas (Dir), who traded 289.5K shares valued at $12.00M on Oct 23, 2026.
Scholar Rock (SRRK) Stock Fair Value Edges Higher After Isembyld Approval And Analyst Revisions
Scholar Rock gains as investors continue to digest early ISEMBYLD launch traction and PRV sale
SRRK - Scholar Rock Holding Corp Stock Price and Quote
Scholar Rock (NASDAQ:SRRK) Stock Price Crosses Above 50 Day Moving Average - Time to Sell?
Scholar Rock (SRRK) Stock Looks Stretched On ISEMBYLD Launch Progress
SRRK Stock Gains After Company Drops Troubled Novo Nordisk-Owned Plant From FDA Filing
FAQs About SRRK Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for SRRK.